To explore the specific mechanism of the cancer-promoting effect of ABCC5 in prostate cancer, we divided the prostate cancer patients in the TCGA-PRAD cohort into an ABCC5 high expression group and an ABCC5 low expression group according to the expression level of ABCC5. The gene discussed is ABCC5; the disease is prostate carcinoma.